文献速递类风湿关节炎

红细胞甲氨蝶呤多聚谷氨酸水平与类风湿关节炎疗效及肝毒性的关联:76周前瞻性研究

Association of erythrocyte methotrexate-polyglutamate levels with the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a 76-week prospective study.
PubMed 文献 · RMD Open · 2017-01-03

该76周前瞻性队列研究纳入79例未用过甲氨蝶呤的类风湿关节炎患者,按预设剂量递增方案治疗,用液相色谱法测定红细胞甲氨蝶呤多聚谷氨酸(MTX-PG)浓度。结果显示MTX-PG浓度与第12周和第24周DAS28改善相关,且与转氨酶升高相关;MTX-PG浓度受体重指数和血清白蛋白影响,提示其可作为疗效与安全性生物标志物。

要点

  • 总MTX-PG浓度与第12周和第24周ΔDAS28显著相关。
  • 转氨酶≥100 IU/L者最大MTX-PG水平显著高于无转氨酶升高者。
  • 第12周总MTX-PG 83 nmol/L为第24周DAS28改善≥1.2的阈值。

核心结论

  • 红细胞MTX-PG浓度是甲氨蝶呤治疗中兼顾疗效与安全性的有用生物标志物。

研究设计与样本

  • 前瞻性76周队列研究,纳入79例未用过甲氨蝶呤的类风湿关节炎患者,按预设剂量递增方案治疗,用液相色谱法测定红细胞MTX-PG浓度。

主要发现

  • 甲氨蝶呤剂量递增导致MTX-PG浓度升高和28关节平均DAS28下降。
  • 总MTX-PG浓度与第12周ΔDAS28显著相关(β=-0.013,p=0.003),与第24周ΔDAS28也显著相关(β=-0.014,p=0.003)。
  • 转氨酶≥100 IU/L者的最大MTX-PG水平显著高于无转氨酶升高者(146 vs 106 nmol/L,p=0.009)。
  • MTX-PG浓度受体重指数和血清白蛋白水平强烈影响。

关键数值与推荐

  • 第12周总MTX-PG浓度83 nmol/L为第24周DAS28改善≥1.2的阈值。
  • 第12周总MTX-PG浓度105 nmol/L为转氨酶≥50 IU/L的阈值,131 nmol/L为转氨酶≥100 IU/L的阈值。

临床怎么用

  • 可监测红细胞MTX-PG浓度以评估甲氨蝶呤疗效和肝毒性风险。
  • 解读MTX-PG浓度时需考虑体重指数和血清白蛋白的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the utility of erythrocyte methotrexate-polyglutamate (MTX-PG) concentrations in determining the safety and efficacy of MTX in patients with rheumatoid arthritis (RA). METHODS: 79 MTX-naïve patients with RA were enrolled in this prospective 76-week cohort study. MTX was initiated, and a predefined dose-escalation protocol was followed. Erythrocyte MTX-PG concentrations were measured using liquid chromatography. The associations of MTX-PG concentrations with disease activity and adverse events were analysed. RESULTS: Dose escalation of MTX resulted in increased MTX-PG concentrations and a decrease in the mean Disease Activity Score in 28 joints (DAS28). A significant association was observed between total MTX-PG concentrations and ΔDAS28 at week 12 (β=-0.013, p=0.003) and at week 24 (β=-0.014, p=0.003). The maximum MTX-PG levels were significantly higher in patients presenting with elevated transaminases (≥100 IU/L) than in those without (146 vs 106 nmol/L, p=0.009). Receiver operating characteristic curve analysis revealed that a total MTX-PG concentrations of 83 nmol/L at week 12 was the threshold for a DAS28 improvement of ≥1.2 at week 24, and 105 nmol/L was the threshold for transaminases of ≥50 IU/L and 131 nmol/L for transaminases of ≥100 IU/L. MTX-PG concentrations were strongly influenced by body mass index and a serum albumin level. CONCLUSIONS: MTX-PG concentrations are a useful biomarker in MTX therapy, in terms of efficacy and safety.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Takahashi C, Kaneko Y, Okano Y, et al. Association of erythrocyte methotrexate-polyglutamate levels with the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a 76-week prospective study. RMD Open. 2017. PMID: 28123781. doi:10.1136/rmdopen-2016-000363

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。